Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Fresenius SE & Co. KGaA    FRE   DE0005785604

FRESENIUS SE & CO. KGAA

(FRE)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Fresenius SE & Co. KGaA: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/30/2019 | 04:05am EDT

DGAP Total Voting Rights Announcement: Fresenius SE & Co. KGaA / Total Voting Rights Announcement
Fresenius SE & Co. KGaA: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

30.04.2019 / 10:02
Total Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Publication of total number of voting rights

1. Details of issuer
Fresenius SE & Co. KGaA
Else-Kröner-Straße 1
61352 Bad Homburg v.d.H.
Germany

2. Type of capital measure
  Type of capital measure Date of status / date of effect
X Conditional capital increase (Sec. 41 para. 2 WpHG) 30.04.2019
  Other capital measure (Sec. 41 para. 1 WpHG)

3. New total number of voting rights:
556448466



30.04.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Fresenius SE & Co. KGaA
Else-Kröner-Straße 1
61352 Bad Homburg v.d.H.
Germany
Internet: www.fresenius.com

 
End of News DGAP News Service

805213  30.04.2019 

fncls.ssp?fn=show_t_gif&application_id=805213&application_name=news&site_id=zonebourse

© EQS 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on FRESENIUS SE & CO. KGAA
09/16FRESENIUS : 2020 DRG inflator for German hospitals set at 3.66%
PU
09/15Fresenius drops possible sale of blood transfusion unit - spokesman
RE
09/13FRESENIUS SE & CO. KGAA : Release according to Article 40, Section 1 of the WpHG..
EQ
09/11FRESENIUS : Helios launches digital portal for patients
PU
09/09FRESENIUS : Medical Care's publishes annual medical report
PU
09/06FRESENIUS : Medical Care builds new laboratory in Mississippi
PU
09/05Fresenius Medical Care to Invest in Its Stem-Cell Subsidiary Unicyte
DJ
09/05FRESENIUS : Medical Care invests EUR 60 million in Unicyte
PU
09/03Fresenius Helios Acquires Two Hospitals in Colombia
DJ
08/30FRESENIUS : Kabi launches IV Drug in the U.S.
PU
More news
Financials (EUR)
Sales 2019 35 385 M
EBIT 2019 4 647 M
Net income 2019 1 839 M
Debt 2019 20 938 M
Yield 2019 1,76%
P/E ratio 2019 13,7x
P/E ratio 2020 12,5x
EV / Sales2019 1,30x
EV / Sales2020 1,15x
Capitalization 25 145 M
Chart FRESENIUS SE & CO. KGAA
Duration : Period :
Fresenius SE & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS SE & CO. KGAA
Short TermMid-TermLong Term
TrendsBullishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 56,68  €
Last Close Price 45,26  €
Spread / Highest target 65,3%
Spread / Average Target 25,2%
Spread / Lowest Target -28,3%
EPS Revisions
Managers
NameTitle
Stephan Sturm President & Chief Executive Officer
Gerd Krick Chairman-Supervisory Board
Rachel Clare Empey Chief Financial Officer
Niko Stumpfögger Deputy Chairman-Supervisory Board
Klaus-Peter Müller Member-Supervisory Board
Sector and Competitors